Magrath George 4
4 · Ocuphire Pharma, Inc. · Filed Nov 3, 2023
Insider Transaction Report
Form 4
Magrath George
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2023-11-01+400,000→ 400,000 total - Award
Employee Stock Option (right to buy)
2023-11-01+600,000→ 600,000 totalExercise: $2.87Exp: 2033-10-31→ Common Stock (600,000 underlying)
Footnotes (2)
- [F1]Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of November 1, 2023.
- [F2]The option will vest with respect to 25% on the first anniversary of the grant date, with the remaining shares vesting in equal monthly installments on the last day of each full month over the subsequent 36 months, subject to continuing service.